SPOTLIGHT -
EP. 1: Genetic Testing in Colorectal Cancer
EP. 2: Broad Molecular Profiling in Colorectal Cancer
EP. 3: Role of Surgery in Metastatic Colorectal Cancer
EP. 4: Impact of the SIRFLOX Study on CRC Management
EP. 5: Daily Aspirin for Colorectal Cancer Prevention
EP. 6: EGFR Inhibition in RAS Wild-Type Unresectable mCRC
EP. 7: Maintenance Therapy in Colorectal Cancer
EP. 8: Immunotherapy in Colorectal Cancer
EP. 9: New Agents for Refractory Metastatic Colorectal Cancer
EP. 10: Global Perspective on the ASCO Annual Meeting
Tusamitamab Ravtansine Plus Pembrolizumab With or Without Chemo Elicits Responses in CEACAM5+ NSCLC
Cemiplimab Monotherapy Induces Durable OS, PFS Benefits in PD-L1+ NSCLC With Brain Metastases
Four Cycles of Chemotherapy Plus Tremelimumab and Durvalumab Demonstrate Optimized Outcomes in Metastatic NSCLC
Taletrectinib Elicits Durable Responses in TKI-Naïve and Crizotinib-Pretreated ROS1+ NSCLC
